Genmab A (GMAB) Short term Debt (2025)

Genmab A (GMAB) has disclosed Short term Debt for 1 consecutive years, with $273.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short term Debt changed N/A year-over-year to $273.0 million, compared with a TTM value of $273.0 million through Dec 2025, changed N/A, and an annual FY2025 reading of $273.0 million, changed N/A over the prior year.
  • Short term Debt was $273.0 million for Q4 2025 at Genmab A.
  • Across five years, Short term Debt topped out at $273.0 million in Q4 2025 and bottomed at $273.0 million in Q4 2025.